MJP
VRTX icon

Michael J. Puzo’s Vertex Pharmaceuticals VRTX Stock Holding History

Michael J. Puzo’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.9M Buy
15,907
+493
+3% +$218K 2.04% 21
2026
Q1 		$6.88M Buy
15,414
+43
+0.3% +$20.1K 2% 24
2025
Q4 		$6.97M Sell
15,371
-130
-0.8% -$56K 1.9% 23
2025
Q3 		$6.07M Buy
15,501
+161
+1% +$67.3K 1.66% 26
2025
Q2 		$6.83M Buy
15,340
+55
+0.4% +$25.3K 1.95% 25
2025
Q1 		$7.41M Buy
15,285
+1,176
+8% +$548K 2.12% 26
2024
Q4 		$5.68M Buy
14,109
+1,872
+15% +$868K 1.59% 28
2024
Q3 		$5.69M Buy
12,237
+2,671
+28% +$1.28M 1.49% 28
2024
Q2 		$4.48M Buy
9,566
+4,953
+107% +$2.15M 1.24% 29
2024
Q1 		$1.93M Buy
4,613
+3,763
+443% +$1.59M 0.53% 38
2023
Q4 		$346K Buy
+850
New +$314K 0.11% 60
2019
Q4 		– Sell
-2,750
Closed -$466K – 82
2019
Q3 		$466K Hold
2,750
– – 0.18% 60
2019
Q2 		$504K Hold
2,750
– – 0.19% 58
2019
Q1 		$506K Sell
2,750
-200
-7% -$36.9K 0.2% 56
2018
Q4 		$489K Sell
2,950
-50
-2% -$8.66K 0.22% 56
2018
Q3 		$578K Hold
3,000
– – 0.22% 56
2018
Q2 		$510K Hold
3,000
– – 0.22% 55
2018
Q1 		$488K Buy
+3,000
New +$490K 0.21% 63

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Michael J. Puzo's VRTX Position: Q2 2026 in Review

Michael J. Puzo increased its Vertex Pharmaceuticals (VRTX) stake by 3.2% in Q2 2026, buying an estimated $218K and bringing the position to 15,907 shares worth $7.9M. The position accounts for 2.04% of the portfolio, ranked #21.

Michael J. Puzo first reported a position in VRTX in Q1 2018 and has held it in 18 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Michael J. Puzo held 15,907 shares of Vertex Pharmaceuticals worth $7.9M as of Q2 2026.
  • Michael J. Puzo bought 493 Vertex Pharmaceuticals shares in Q2 2026, an estimated $218K.
  • Vertex Pharmaceuticals made up 2.04% of Michael J. Puzo's portfolio in Q2 2026, its #21 holding.
  • Michael J. Puzo first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 18 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Michael J. Puzo's 13F filing for Q2 2026, filed 11 Aug 2026.